Deborah V. Davis Ascheim MD
Heart Failure & Transplantation
Professor, Population Heallth Science & Policy / Medicine (Cardiology), Icahn School of Medicine at Mount Sinai
Join to view full profile
5 E 98th St3rd FloorNew York, NY 10029
Phone+1 212-427-1540
Fax+1 212-410-7196
Dr. Ascheim is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital(Cornell Campus)/Coney Island HospitalFellowship, Cardiovascular Disease, 1993 - 1996- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1990 - 1993
New York University School of MedicineClass of 1990
Certifications & Licensure
NY State Medical License 1992 - 2027
CA State Medical License 2015 - 2026
Clinical Trials
Publications & Presentations
PubMed
- 1 citationsFibroblast growth factor 21 prevents catecholaminergic arrhythmias in a mouse model of PKP2 arrhythmogenic cardiomyopathy.Xianming Lin, Noah Davidsohn, Sarah Boyce, Maritza McIntyre, Mingliang Zhang
Heart Rhythm. 2026-08-01 - 1 citationsRationale and design of MUSIC-HFpEF: a phase 1b, pilot trial evaluating the safety and pharmacodynamic effects of AAV1.SERCA2A in heart failure with preserved ejection...Marat Fudim, Satyam Sarma, James P MacNamara, Deborah D Ascheim, Veraprapas Kittipibul
Heart Failure Reviews. 2026-01-17 - 52 citationsRepeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled,...Craig M McDonald, Eduardo Marbán, Suzanne Hendrix, Nathaniel Hogan, Rachel Ruckdeschel Smith
Lancet. 2022-03-12
Press Mentions
CIRM $4 Million Awarded to Support Innovative Gene Therapy for Rare Heart DisorderSeptember 16th, 2024- Rejuvenate Bio Appoints Deborah Ascheim, M.D., as Chief Medical OfficerJanuary 3rd, 2023
- Genentech Alum Jane Grogan Goes Startup Hopping from ArsenalBio to Graphite Bio; Scott Holmes to Handle CFO Duties at Catamaran Bio, Teaming up Again with Ex-Disarm CEOApril 30th, 2021
Committees
- member, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
